Description

Fragmin Solution for Injections 2500 IU 0.2 ml. №10

Ingredients:

Each 0.2 ml ampoule contains 2500 IU of dalteparin sodium as the active ingredient.

Mechanism of Action:

Dalteparin, a low molecular weight heparin, acts as an anticoagulant by enhancing the inhibition of factor Xa.

Pharmacological Properties:

Fragmin exhibits anticoagulant properties and is effective in preventing venous thromboembolism in various clinical settings.

Indications for Use:

• Prevention of deep vein thrombosis
• Treatment of deep vein thrombosis
• Prevention of clotting during hemodialysis
• Treatment of unstable angina
• Treatment of non-Q-wave myocardial infarction

Contraindications:

Do not use Fragmin in patients with active major bleeding, bacterial endocarditis, or a history of heparin-induced thrombocytopenia. Avoid use in patients with hypersensitivity to dalteparin or pork products.

Side Effects:

Common side effects of Fragmin may include bleeding, bruising, and injection site reactions.

Usage Instructions:

Administer Fragmin subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites and avoid rubbing the site after administration.

Benefits Compared to Analogues:

Fragmin is preferred in many clinical scenarios due to its predictable anticoagulant effect and lower risk of heparin-induced thrombocytopenia compared to unfractionated heparin.

Suitable Patient Groups:

Fragmin is suitable for use in various patient populations, including children and the elderly, under appropriate medical supervision.

Storage Conditions and Shelf Life:

Store Fragmin as per the instructions provided and check the expiration date before use.

Packaging Description:

Fragmin solution for injections comes in ampoules containing 2500 IU of dalteparin sodium in 0.2 ml solution, packaged in boxes of 10 ampoules.

Clinical Evidence and Proven Effectiveness:

Fragmin has been extensively studied in clinical trials, demonstrating efficacy and safety in various thrombotic events. It is established as a first-line anticoagulant therapy in many clinical conditions.